Global Clinical Trials Matching Software Market Size study, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), and Regional Forecasts 2022-2028

Global Clinical Trials Matching Software Market Size study, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), and Regional Forecasts 2022-2028

Global Clinical Trials Matching Software Market is valued at approximately USD 132.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.07% over the forecast period 2022-2028. Clinical trial matching software help patients and their proxies (e.g., caregivers and providers) enroll in clinical trials by identifying potential trials and, in some cases, providing additional support services such as educational materials or personnel who can answer questions or assist patients. Factors such as Surge in number of clinical trials globally, Growing prevalence of infectious and chronic diseases, increase in the outsourcing of clinical research are driving the growth of market. For instance, according to registry of clinical trials ClinicalTrials.gov – during April 2020, the registered COVID-19 studies worldwide were estimated at just 260 trials and as of March 2021, the number of studies increased to 4,992 trials. Moreover, Rising digitization in healthcare sector and Increasing R& D Funding activities in Clinical Research are few other factors creating new opportunities for the market growth over the forecast period. However, high deployment & maintenance costs associated with Clinical Trials Matching Solutions are the major factors impeding the market growth over the forecast period of 2022-2028.

The regional analysis of the global Clinical Trials Matching Software market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to the ongoing clinical trials activities, high number of clinical trials activities along with the presence of a significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 growing healthcare expenditure in the region, increase in number of clinical trials which is increasing the demand for the software. Along with this, high government support for the clinical trials development is also driving the growth for the region over the forecasted period.

Major market player included in this report are:
IBM Clinical development
Antidote Technologies, Inc.
Clinical Trials Mobile Application
SSS International Clinical Research
Advarra
Aris Global
MasterControl, Inc.
DZS Clinical Services
Yprime LLC
Dacima Software Inc


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Deployment Type
Web & Cloud Based
On-premise
By End Use:
Pharmaceutical & Biotechnology Companies
CROs
Medical device firm
By Distribution Channel:
Supermarkets/Hypermarkets
Online Stores
Convenience Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018, 2019
Base year – 2021
Forecast period – 2022 to 2027

Target Audience of the Global Clinical Trials Matching Software Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

IBM Clinical development
Antidote Technologies, Inc.
Clinical Trials Mobile Application
SSS International Clinical Research
Advarra
Aris Global
MasterControl, Inc.
DZS Clinical Services
Yprime LLC
Dacima Software Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.